Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Misses Revenue Estimates

分组1 - Sol-Gel Technologies Ltd. reported a quarterly loss of $1.07 per share, significantly worse than the Zacks Consensus Estimate of $0.39, representing an earnings surprise of -374.36% [1] - The company posted revenues of $0.7 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 89.29%, compared to revenues of $0.28 million a year ago [2] - The stock has increased by approximately 78.8% since the beginning of the year, while the S&P 500 has declined by 3.2% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$1.84 on revenues of $0.9 million, and for the current fiscal year, it is -$6.81 on revenues of $5.28 million [7] - The Medical - Generic Drugs industry, to which Sol-Gel Technologies belongs, is currently ranked in the bottom 23% of over 250 Zacks industries, indicating potential challenges for stock performance [8]